Lifebit to Build ‘Data Bridge,’ Revolutionising Precision Medicine
NIHR Cambridge Biomedical Research Centre (NIHR Cambridge BRC), together with Genomics England (GEL), Eastern AHSN (Academic Health Science Network), Cambridge University Health Partners (CUHP) and the precision medicine software company Lifebit have been awarded £200,000 by UK Research and Innovation as part of the DARE UK (Data and Analytics Research Environments UK) programme, to develop and test a […]
Lifebit certified for data transformation by EHDEN
What is the European Health Data and Evidence Network? EHDEN was established in response to the volume of real-world health data available in Europe today and the associated challenges this brings with respect to policy, regulatory and technology considerations. EHDEN is standardising how large-scale clinical data can be tapped into by patients, clinicians, payers, regulators, governments, […]
Lifebit Raises $60M to Make Biomedical Data Accessible for Research
LONDON, UK – 28 September 2021 – Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data of governments, biobanks and healthcare providers for research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm Tiger Global Management. Existing investors Eurazeo, Pentech Ventures, and […]
Lifebit Announces Support for New AWS for Health Initiative
Lifebit is proud to announce support for the AWS for Health Initiative from Amazon Web Services (AWS) to empower Public Sector organisations to build innovative, scalable and collaborative cloud-based solutions for national precision medicine initiatives worldwide. This commitment aligns with our dedication to the Health Initiative, enhancing healthcare capabilities across various sectors. What is the […]
Boehringer Ingelheim Partners With Lifebit to Detect Disease Outbreaks
London, United Kingdom, June 9, 2021 – Lifebit Biotech Ltd announces the beginning of a long-term partnership with Boehringer Ingelheim to utilise Natural Language Processing (NLP) and Artificial Intelligence (AI) for the detection and early reporting of global disease outbreaks using real-world data harvested from scientific publications and other open sources. Utilising the Lifebit REAL platform, […]
Lifebit Joins the Alliance for Artificial Intelligence in Healthcare
What is the Alliance for Artificial Intelligence in Healthcare? AI in healthcare is essential for driving innovation. AAIH represents a coordinated, global effort across the healthcare, life science and technology industries to ensure there is a responsible adoption and application of AI/ML in healthcare. The alliance’s particular areas of focus include AI-guided pharmaceutical development, advanced […]
Lifebit Awarded Four-Year Contract for Hong Kong’s Genome Project
London, UK – 25 May 2021: The leader in population genomics platform and precision medicine technology, Lifebit Biotech Ltd, today announced it has been awarded a four-year contract by Hong Kong’s Genome Institute (HKGI) to support its implementation of the Hong Kong Genome Project (Project), the first large-scale genome sequencing initiative in Hong Kong. Lifebit offers […]
Lifebit Selected by EHDEN to Accelerate Health Data Mapping
As part of the EHDEN network, Lifebit will support a diverse ecosystem of European institutions in performing mappings and harmonising their clinical data, focusing on health data mapping, and will actively contribute to EHDEN’s large-scale, federated network of OMOP CDM standardised data sources. Advancements in Health Data Mapping The coordinated efforts of the network will […]
Lifebit CEO Dr Maria Chatzou-Dunford at AWS Startup Industry Days 2021
In the session, Dr Chatzou Dunford along with Patrick Lamplé, AWS Senior Specialist Solutions Architect for Healthcare and Life Sciences, discussed the technical and practical aspects of building data platforms using AWS – from data ingestion to analytics and machine learning. AWS Startup Industry Days: A Platform for Innovation One of the key highlights was […]
Clinico-Genomics Data: Is The Next Leap in Drug Development The Right Approach?
Clinico-genomics in drug development is rapidly emerging as a transformative approach that combines clinical and genomic data to deliver better, faster therapeutic outcomes. In the era of precision medicine, integrating these data types is no longer optional—it’s essential for success. As genomic, phenotypic and clinical data are continuously being generated at an exponential pace, the […]